Herpes simplex type 2 infections--an update.
Marques
A R
AR
Clinical Studies Unit and Medical Virology Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Straus
S E
SE
D000998:Antiviral Agents / Q000627:therapeutic use; D004351:Drug Resistance; D005260:Female; D006558:Herpes Genitalis / Q000175:diagnosis / Q000453:epidemiology / Q000276:immunology / Q000503:physiopathology / Q000628:therapy / Q000635:transmission / Q000821:virology; D018258:Herpesvirus 2, Human; D006801:Humans; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical; D008297:Male; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000821:virology; D012307:Risk Factors; D014765:Viral Vaccines
D000998:Antiviral Agents; D014765:Viral Vaccines